Please assess the completion status of the following clinical trial:

Trial Title: Intensive Lifestyle Interventions to Overweight and Obese Patients in Primary Care

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CROSSOVER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Age 18-40 BMI ≥ 25 kg/m 2 Agreeing to participate in the study Not having a diagnosed chronic disease To be able to ambulate To be cooperative~Exclusion Criteria:~* Receiving medical treatment~* Secondary obesity (hypothyroidism, Cushing\&#39;s disease, etc.)~* Chronic disease (cardiovascular diseases, pulmonary diseases, presence of diabetes mellitus, liver diseases, renal diseases)~* Having hyperlipidaemia under treatment~* Cancer~* Pregnancy or breastfeeding~* Psychiatric disorder~* Orthopaedic or neurological disease that may prevent walking~* Are currently taking weight loss medication or enrolled in another weight loss program~* Having previously undergone obesity surgery or having surgery planned during the study period

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: None

Study Arms:
- Intervention group (Type: None): They were given a calorie-restricted diet and exercise plan by a dietician or physiotherapist at their first visit, and were followed up by telephone calls at weeks 2, 4, 6, 8 and 10 over 12 weeks.
- Control-1 group (Type: None): During the initial medical interview, the participants were given a calorie-restricted diet programme by a dietician and an exercise programme by a physiotherapist; they were followed up over 12 weeks with telephone calls at week 4.
- Control-2 group (Type: None): During the initial medical interview, the participants were given a calorie-restricted diet programme by a dietician and an exercise programme by a physiotherapist; they were followed up over 12 weeks with telephone calls at week 4.

Based on this trial design, predict the completion outcome and termination type (if applicable).